Enter your number to get our free mobile app

An end may be near.

Early this morning, drug maker Pfizer announced that their COVID-19 vaccine trial has shown to be 90% effective in their trials. The company filed for Emergency Use Authorization with the FDA today.

Senior Vice President for Vaccine Clinical Research for Pfizer, William Gruber, told Bloomberg:

“This is about the best the news could possibly be for the world and for the United States and for public health,”

The Pfizer vaccine is a two dose vaccine, and patients will need about three weeks between shots. The national rollout of the vaccine will not start until the FDA issues authorization.

In the moments after the announcement from the drug maker, the stock market shot up. Including shares of companies like the cruise ship industry.

In addition to this news, this is just one vaccine. There are multiple others in Phase 3 trials, and news on those could come soon.